Actively Recruiting

Phase 2
Age: 18Years - 36Years
All Genders
Healthy Volunteers
NCT03989778

Vitamin D and Polycystic Ovarian Syndrome (PCOS)

Led by Aga Khan University · Updated on 2025-02-19

300

Participants Needed

2

Research Sites

127 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Primary Objectives: To evaluate the efficacy of metformin and Vitamin D supplementation on serum insulin and serum androgen levels (Total testosterone, Steroid Hormone Binding Globulin, Free Androgen Index) levels compared metformin alone in infertile Poly cystic ovarian females of reproductive age group. Secondary Objectives: To measure change in endometrial thickness/number of follicles and follicular size by day 12 trans-vaginal ultrasound in the intervention group i.e. combination of metformin and vitamin D supplementation

CONDITIONS

Official Title

Vitamin D and Polycystic Ovarian Syndrome (PCOS)

Who Can Participate

Age: 18Years - 36Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Female aged 18 to 36 years
  • Diagnosed with primary infertility and PCOS with at least two of these: hyperandrogenism, chronic anovulation, and polycystic ovaries
  • Vitamin D deficiency with serum levels below 25 nmol/L
  • From any ethnic background
Not Eligible

You will not qualify if you...

  • Secondary infertility
  • Hypercalcemia with plasma calcium concentrations above 2.65 mmol/L
  • Tuberculosis or other granulomatous disorders
  • Current use of vitamin D replacement, oral contraceptives, hormonal replacement therapy, glucocorticoids, calcium supplements, insulin-sensitizing drugs, lipid-lowering drugs, or other drugs affecting insulin sensitivity or serum androgens in the past 3 months
  • Use of anti-epileptics, anti-retroviral drugs, cholestyramine, anti-fungal, statins, H2 blockers, immunosuppressants, chemotherapeutic agents, or antimicrobials affecting lipid metabolism in the past 3 months
  • Diagnosis of congenital adrenal hyperplasia, Cushing's syndrome, androgen-secreting tumors, type 2 diabetes mellitus, renal, hepatic, or thyroid disorders
  • Hyperparathyroidism, malabsorption syndromes, chronic kidney disease, hepatic failure, cystic fibrosis
  • Vaginal bleeding of unknown cause
  • History of bariatric surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Dr Rehana Rehman

Karachi, Sindh, Pakistan, 74800

Actively Recruiting

2

Dr Rehana Rehman

Karachi, Sindh, Pakistan, 75500

Actively Recruiting

Loading map...

Research Team

R

Rehana K Rehman, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here